Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03089853 · ClinicalTrials.gov registry record · NA

Smart Telehealth Exercise Intervention to Reduce COPD Readmissions

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT03089853 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03089853, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This is a prospective randomized controlled study to test the hypothesis that neuromuscular electrical stimulation (NMES) and remote pulmonary rehabilitation at home offered via a smart technology, called Smart TeleHealth, results in a reduction of systemic inflammation, via reduction of skeletal muscle tissue inflammation, and thereby improves functional capacity, and thus, reduces the rate of readmissions following hospitalization for acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). This study will enroll up to 40 participants at the University of Alabama at Birmingham (UAB), about 30 will get Smart Telehealth and NMES, and 10 will get usual care.

Interventions

  • DEVICE Neuromuscular electrical stimulation (NMES)

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2016-07-14
Est. Completion 2020-08-15
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03089853

The ClinicalTrials.gov registry entry for NCT03089853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Neuromuscular electrical stimulation (NMES) is the first listed.

NCT03089853 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03089853 about?

NCT03089853 is a clinical study titled "Smart Telehealth Exercise Intervention to Reduce COPD Readmissions". This is a prospective randomized controlled study to test the hypothesis that neuromuscular electrical stimulation (NMES) and remote pulmonary rehabilitation at home offered via a smart technology, called Smart TeleHealth, results in a reduction of systemic inflammation, via reduction of skeletal mu...

What is the current status of trial NCT03089853?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-07-14. Estimated completion is 2020-08-15.

What interventions are being tested in trial NCT03089853?

The interventions under investigation include: Neuromuscular electrical stimulation (NMES) (DEVICE).

Who is sponsoring clinical trial NCT03089853?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.